XJPX
7681
Market cap11mUSD
Jul 09, Last price
912.00JPY
1D
1.45%
1Q
4.83%
IPO
-33.59%
Name
Leoclan Co Ltd
Chart & Performance
P/E
11.70
P/S
0.08
EPS
77.92
Div Yield, %
1.86%
Shrs. gr., 5y
0.23%
Rev. gr., 5y
-0.47%
Revenues
21.49b
+8.51%
Net income
153m
+12.29%
CFO
-87m
L
Dividend
Sep 29, 202617 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
LEOCLAN Co.,Ltd. operates as a medical equipment trading firm, addressing diverse needs across medical care, welfare, and general health sectors. Its operations are structured into three main divisions: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment delivers comprehensive services. This includes advisory support for selecting medical equipment, subsequent maintenance, and undertaking interior design, construction, and installation projects for medical facilities, preventive health centers, and nursing care institutions. Additionally, this segment is involved in the sale of medical devices and information systems. Through its Remote Image Diagnosis Service Business, the company facilitates the remote interpretation of imaging data from MRI, CT, and other scans by diagnostic radiology specialists, subsequently providing critical diagnostic information. Finally, the School Lunch Business segment offers a variety of meal services—including regular, therapeutic, and other specialized dietary options—to nursing care and welfare facilities. Established in 2001, LEOCLAN Co.,Ltd. is headquartered in Settsu, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||